MMP9 and breast cancer: Western blot proved that the metastasis associated proteins MMP9 and FAK expression were inhibited in the miR-18a-3p inhibitor group, and inhibited expression of miR-18a-3p can enhance the function of HHT on breast cancer cells (Fig. 6c).